Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients.
The heterogeneity among multiple ductal carcinoma in situ (DCIS) lesions within the same patient also diagnosed with invasive ductal carcinoma (IDC) has not been well evaluated, leaving research implications of intra-individual DCIS heterogeneity yet to be explored. In this study formalin-fixed para...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/cf46ecc989014c7eb753319216f40d81 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:cf46ecc989014c7eb753319216f40d81 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:cf46ecc989014c7eb753319216f40d812021-11-25T06:10:24ZIdentifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients.1932-620310.1371/journal.pone.0100488https://doaj.org/article/cf46ecc989014c7eb753319216f40d812014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24978026/?tool=EBIhttps://doaj.org/toc/1932-6203The heterogeneity among multiple ductal carcinoma in situ (DCIS) lesions within the same patient also diagnosed with invasive ductal carcinoma (IDC) has not been well evaluated, leaving research implications of intra-individual DCIS heterogeneity yet to be explored. In this study formalin-fixed paraffin embedded sections from 36 patients concurrently diagnosed with DCIS and IDC were evaluated by immunohistochemistry. Ten DCIS lesions from each patient were then randomly selected and scored. Our results showed that expression of PR, HER2, Ki-67, and p16 varied significantly within DCIS lesions from a single patient (P<0.05 for PR; P<1×10(-8) for HER2, Ki-67 and p16). In addition, seventy-two percent of the individuals had heterogeneous expression of at least 2/6 markers. Importantly, by evaluating the expression of promising DCIS risk biomarkers (Ki-67, p53 and p16) among different DCIS subgroups classified by comparing DCIS molecular subtypes with those of adjacent normal terminal duct lobular units (TDLU) and IDC, our results suggest the existence of a highly-aggressive DCIS subgroup, which had the same molecular subtype as the adjacent IDC but not the same subtype as the adjacent normal TDLU. By using a systematic approach, our results clearly demonstrate that intra-individual heterogeneity in DCIS is very common in patients concurrently diagnosed with IDC. Our novel findings of a DCIS subpopulation with aggressive characteristics will provide a new paradigm for mechanistic studies of breast tumor progression and also have broad implications for prevention research as heterogeneous pre-invasive lesions are present in many other cancer types.Dana Pape-ZambitoZhengyu JiangHong WuKarthik DevarajanCarolyn M SlaterKathy Q CaiArthur PatchefskyMary B DalyXiaowei ChenPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 6, p e100488 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Dana Pape-Zambito Zhengyu Jiang Hong Wu Karthik Devarajan Carolyn M Slater Kathy Q Cai Arthur Patchefsky Mary B Daly Xiaowei Chen Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients. |
| description |
The heterogeneity among multiple ductal carcinoma in situ (DCIS) lesions within the same patient also diagnosed with invasive ductal carcinoma (IDC) has not been well evaluated, leaving research implications of intra-individual DCIS heterogeneity yet to be explored. In this study formalin-fixed paraffin embedded sections from 36 patients concurrently diagnosed with DCIS and IDC were evaluated by immunohistochemistry. Ten DCIS lesions from each patient were then randomly selected and scored. Our results showed that expression of PR, HER2, Ki-67, and p16 varied significantly within DCIS lesions from a single patient (P<0.05 for PR; P<1×10(-8) for HER2, Ki-67 and p16). In addition, seventy-two percent of the individuals had heterogeneous expression of at least 2/6 markers. Importantly, by evaluating the expression of promising DCIS risk biomarkers (Ki-67, p53 and p16) among different DCIS subgroups classified by comparing DCIS molecular subtypes with those of adjacent normal terminal duct lobular units (TDLU) and IDC, our results suggest the existence of a highly-aggressive DCIS subgroup, which had the same molecular subtype as the adjacent IDC but not the same subtype as the adjacent normal TDLU. By using a systematic approach, our results clearly demonstrate that intra-individual heterogeneity in DCIS is very common in patients concurrently diagnosed with IDC. Our novel findings of a DCIS subpopulation with aggressive characteristics will provide a new paradigm for mechanistic studies of breast tumor progression and also have broad implications for prevention research as heterogeneous pre-invasive lesions are present in many other cancer types. |
| format |
article |
| author |
Dana Pape-Zambito Zhengyu Jiang Hong Wu Karthik Devarajan Carolyn M Slater Kathy Q Cai Arthur Patchefsky Mary B Daly Xiaowei Chen |
| author_facet |
Dana Pape-Zambito Zhengyu Jiang Hong Wu Karthik Devarajan Carolyn M Slater Kathy Q Cai Arthur Patchefsky Mary B Daly Xiaowei Chen |
| author_sort |
Dana Pape-Zambito |
| title |
Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients. |
| title_short |
Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients. |
| title_full |
Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients. |
| title_fullStr |
Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients. |
| title_full_unstemmed |
Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients. |
| title_sort |
identifying a highly-aggressive dcis subgroup by studying intra-individual dcis heterogeneity among invasive breast cancer patients. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/cf46ecc989014c7eb753319216f40d81 |
| work_keys_str_mv |
AT danapapezambito identifyingahighlyaggressivedcissubgroupbystudyingintraindividualdcisheterogeneityamonginvasivebreastcancerpatients AT zhengyujiang identifyingahighlyaggressivedcissubgroupbystudyingintraindividualdcisheterogeneityamonginvasivebreastcancerpatients AT hongwu identifyingahighlyaggressivedcissubgroupbystudyingintraindividualdcisheterogeneityamonginvasivebreastcancerpatients AT karthikdevarajan identifyingahighlyaggressivedcissubgroupbystudyingintraindividualdcisheterogeneityamonginvasivebreastcancerpatients AT carolynmslater identifyingahighlyaggressivedcissubgroupbystudyingintraindividualdcisheterogeneityamonginvasivebreastcancerpatients AT kathyqcai identifyingahighlyaggressivedcissubgroupbystudyingintraindividualdcisheterogeneityamonginvasivebreastcancerpatients AT arthurpatchefsky identifyingahighlyaggressivedcissubgroupbystudyingintraindividualdcisheterogeneityamonginvasivebreastcancerpatients AT marybdaly identifyingahighlyaggressivedcissubgroupbystudyingintraindividualdcisheterogeneityamonginvasivebreastcancerpatients AT xiaoweichen identifyingahighlyaggressivedcissubgroupbystudyingintraindividualdcisheterogeneityamonginvasivebreastcancerpatients |
| _version_ |
1718414131281788928 |